196 POSTER A phase I trial incorporating the pharmacodynamic (PD) study of circulating tumour cells (CTC) of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), in combination with docetaxel (D) in patients (p) with advanced cancer

✍ Scribed by P.C. Fong; R.L. Molife; J. Spicer; T.A. Yap; S. Settatree; L. Digue; G. Attard; V. Karavasilis; A. Gualberto; J.S. de Bono

• Book ID: 118623824
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 71 KB
• Volume: 4
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(06)70201-4